Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2

Ma'ayan Israeli; Yaara Finkel; Yfat Yahalom-Ronen; Nir Paran; Theodor Chitlaru; Ofir Israeli; Inbar Cohen-Gihon; Moshe Aftalion; Reut Falach; Shahar Rotem; Uri Elia; Ital Nemet; Limor Kliker; Michal Mandelboim; Adi Beth-Din; Tomer Israely; Ofer Cohen; Noam Stern-Ginossar; Adi Bercovich-Kinori

doi:10.1038/s41467-022-29896-z

Back

Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2

Journal article

an open version is available

Peer reviewed

Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2

Ma'ayan Israeli, Yaara Finkel, Yfat Yahalom-Ronen, Nir Paran, Theodor Chitlaru, Ofir Israeli, Inbar Cohen-Gihon, Moshe Aftalion, Reut Falach, Shahar Rotem, …

Nature communications, Vol.13, 2237

25/Apr/2022

DOI: https://doi.org/10.1038/s41467-022-29896-z

PMID: 35469023

Files and links (1)

url

https://doi.org/10.1038/s41467-022-29896-zView

Published (Version of record)CC BY V4.0, Open Access

Abstract

The global spread of SARS-CoV-2 led to major economic and health challenges worldwide. Revealing host genes essential for infection by multiple variants of SARS-CoV-2 can provide insights into the virus pathogenesis, and facilitate the development of novel therapeutics. Here, employing a genome-scale CRISPR screen, we provide a comprehensive data-set of cellular factors that are exploited by wild type SARS-CoV-2 as well as two additional recently emerged variants of concerns (VOCs), Alpha and Beta. We identified several host factors critical for SARS-CoV-2 infection, including various components belonging to the Clathrin-dependent transport pathway, ubiquitination, Heparan sulfate biogenesis and host phosphatidylglycerol biosynthesis. Comparative analysis of the different VOCs revealed the host factors KREMEN2 and SETDB1 as potential unique candidates required only to the Alpha variant. Furthermore, the analysis identified GATA6, a zinc finger transcription factor, as an essential proviral gene for all variants inspected. We show that GATA6 directly regulates ACE2 transcription and accordingly, is critical for SARS-CoV-2 cell entry. Analysis of clinical samples collected from SARS-CoV-2 infected individuals shows elevated levels of GATA6, suggesting a role in COVID-19 pathogenesis. Finally, pharmacological inhibition of GATA6 resulted in down-modulation of ACE2 and inhibition of viral infectivity. Overall, we show GATA6 may represent a target for the development of anti-SARS-CoV-2 therapeutic strategies and reaffirm the value of the CRISPR loss-of-function screens in providing a list of potential new targets for therapeutic interventions.

Details

Title: Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2
Creators: Ma'ayan Israeli - Israel Institute for Biological Research
Yaara Finkel - 972WIS_INST___111
Yfat Yahalom-Ronen - Israel Institute for Biological Research
Nir Paran - Israel Institute for Biological Research
Theodor Chitlaru - Israel Institute for Biological Research
Ofir Israeli - Israel Institute for Biological Research
Inbar Cohen-Gihon - Israel Institute for Biological Research
Moshe Aftalion - Israel Institute for Biological Research
Reut Falach - Israel Institute for Biological Research
Shahar Rotem - Israel Institute for Biological Research
Uri Elia - Israel Institute for Biological Research
Ital Nemet - Sheba Medical Center
Limor Kliker - Sheba Medical Center
Michal Mandelboim - 972WIS_INST___088661e2-4064-44d5-bbf3-69a740a190cd
Adi Beth-Din - Israel Institute for Biological Research
Tomer Israely - Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel
Ofer Cohen - Israel Institute for Biological Research
Noam Stern-Ginossar - 972WIS_INST___111
Adi Bercovich-Kinori - Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel. adiki@iibr.gov.il
Resource Type: Journal article
Publication Details: Nature communications, Vol.13, 2237; 25/Apr/2022
Language: English
DOI: https://doi.org/10.1038/s41467-022-29896-z
PMID: 35469023
Grant note: We thank Emanuelle Mamroud for providing valuable feedback; Tamar Aminov and Inbar Chomsky for technical assistance; and Shay Weiss for biosafety guidance. Contributions M.I., Y.F., N.P., O.C., N.S.-G., and A.B.-K. conceptualized the study; M.I., O.I., M.A., R.F., U.E., and A.B.-K. performed experiments; I.N., L.K., and M.M. provided reagents. Y.F., I.C.-G., A.B.-D., S.R., and A.B.-K. undertook data analysis; Y.Y.-R., N.P., and T.I. performed experiments with SARS-CoV-2; M.I., Y.F., T.C., N.P., and A.B.-K. interpreted data; and A.B.-K. and T.C. wrote the manuscript with contributions from all other authors.
Record Identifier: 993358453203596

Metrics

7 Record Views

See more details